#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	814	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1332	32.9	0	.	p	.	0	K29T	NONSYN	85	87	AAG	440	442	ACG	38;40;40	A;C;G	38;40;40	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	179	3012	Escherichia_coli_EF_Tu	1185	1183	99.75	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1342	110.0	0	HET	.	.	.	T135C	.	135	135	T	133	133	T	106	T,C	63,31	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	179	3012	Escherichia_coli_EF_Tu	1185	1183	99.75	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1342	110.0	0	HET	.	.	.	T1167A	.	1167	1167	T	1165	1165	T	53	T,A	36,17	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	179	3012	Escherichia_coli_EF_Tu	1185	1183	99.75	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1342	110.0	0	HET	.	.	.	T1170A	.	1170	1170	T	1168	1168	T	53	T,A	36,17	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	179	3012	Escherichia_coli_EF_Tu	1185	1183	99.75	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1342	110.0	0	HET	.	.	.	C951A	.	951	951	C	949	949	C	125	C,A	66,59	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	179	3012	Escherichia_coli_EF_Tu	1185	1183	99.75	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1342	110.0	0	HET	.	.	.	C216T	.	216	216	C	214	214	C	110	C,T	72,38	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1404	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1972	38.1	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1656	1658	AAA	18;17;16	A;A;A	18;17;16	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1702	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c4.ctg.1	1792	50.8	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1282	1284	GAA	71;73;74	G;A;A	71;72;74	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	446	H_NS	414	414	99.03	H_NS.l15.c4.ctg.1	990	24.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	204	G	199	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	199	C	198	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	176	C	174	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	223	T	222	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	223	C	222	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	153	C,A	150,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	141	A	140	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	138	A	138	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	140	A	140	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	130	T,C	126,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	125	C	125	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	126	C	126	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	127	A	127	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	124	G	124	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	122	C	122	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	141	T,G	139,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	189	G	189	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	207	G	207	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	215	T	215	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	194	T,G	192,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	190	G	189	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	156	C	155	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	136	A	135	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	130	C	130	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	124	C	124	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	63	A	62	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	63	A	63	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	54	G	54	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	59	C	59	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	125	T	124	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	144	G	143	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	105	T	105	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.6	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	263	C,T,G	260,1,1	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	140	90.71	Pasteurella_multocida_16S.l15.c17.ctg.3	140	57.5	0	.	n	.	0	C990G	SNP	990	990	C	38	38	G	37	G	24	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	140	90.71	Pasteurella_multocida_16S.l15.c17.ctg.3	140	57.5	0	.	n	.	0	T1002A	SNP	1002	1002	T	50	50	A	43	A	42	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	140	90.71	Pasteurella_multocida_16S.l15.c17.ctg.3	140	57.5	0	.	n	.	0	A1004G	SNP	1004	1004	A	52	52	G	41	G	41	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	140	90.71	Pasteurella_multocida_16S.l15.c17.ctg.3	140	57.5	0	.	n	.	0	C1011T	SNP	1011	1011	C	59	59	T	46	T	45	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	140	90.71	Pasteurella_multocida_16S.l15.c17.ctg.3	140	57.5	0	.	n	.	0	C1023A	SNP	1023	1023	C	71	71	A	59	A	59	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	140	90.71	Pasteurella_multocida_16S.l15.c17.ctg.3	140	57.5	0	.	n	.	0	T1024A	SNP	1024	1024	T	72	72	A	59	A,T	57,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	140	90.71	Pasteurella_multocida_16S.l15.c17.ctg.3	140	57.5	0	.	n	.	0	T1041G	SNP	1041	1041	T	89	89	G	88	G	88	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4612	Pasteurella_multocida_16S	1551	140	90.71	Pasteurella_multocida_16S.l15.c17.ctg.3	140	57.5	0	.	n	.	0	A1042T	SNP	1042	1042	A	90	90	T	88	T	88	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1334	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1736	41.4	0	.	p	.	0	H2R	NONSYN	4	6	CAT	321	323	CGT	48;48;47	C;G;T	48;48;47	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1334	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1736	41.4	0	.	p	.	0	V30I	NONSYN	88	90	GTC	405	407	ATC	59;57;55	A;T;C	58;57;55	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1334	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1736	41.4	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1164	1166	GGC	51;52;53	G;G;C	50;51;53	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1702	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2086	43.7	0	.	p	.	0	R8S	NONSYN	22	24	AGA	250	252	AGC	28;30;32	A;G;C	28;30;32	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1702	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2086	43.7	0	.	p	.	0	I142L	NONSYN	424	426	ATA	652	654	CTA	46;47;47	C;T;A,G	46;45;46,1	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1702	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2086	43.7	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1171	1173	CAA	45;44;44	C;A;A	45;44;44	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1702	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2086	43.7	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1270	1272	GGT	62;62;61	G;G;T	62;61;61	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1702	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2086	43.7	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1840	1842	GTT	27;28;26	G;T;T	27;28;26	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	816	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1755	24.9	0	.	p	.	0	A125E	NONSYN	373	375	GCA	680	682	GAA	32;32;34	G;A;A	32;32;34	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	816	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1755	24.9	0	.	p	.	0	M185T	NONSYN	553	555	ATG	860	862	ACC	15;15;16	A;C;C	15;15;16	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	816	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1755	24.9	0	.	p	.	0	S225T	NONSYN	673	675	TCC	980	982	ACT	14;15;15	A;C;T	14;15;15	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	816	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1755	24.9	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1370	1372	ATC	22;24;24	A;T;C	22;24;24	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	1104	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1503	39.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	1020	aad-	789	789	100.0	aad-.l6.c30.ctg.1	1411	38.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3012	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3676	44.0	0	.	p	.	0	T85I	NONSYN	253	255	ACC	587	589	ATC	50;50;50	A;T;C	50;50;50	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3012	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3676	44.0	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2300	2302	AAG	32;32;33	A;A;G	32;32;33	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1168	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1808	34.7	0	.	p	.	0	A22V	NONSYN	64	66	GCC	360	362	GTC	22;21;23	G;T;C	22;21;22	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1168	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1808	34.7	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1101	1103	TGC	53;48;48	T;G;C	53;48;48	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2814	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3126	48.0	0	.	p	.	0	S46trunc	TRUNC	136	136	T	386	386	T	31	T	31	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2814	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3126	48.0	0	.	p	.	0	G148D	NONSYN	442	444	GGC	692	694	GAC	50;50;52	G;A;C	49;50;50	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2814	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3126	48.0	0	.	p	.	0	F240L	NONSYN	718	720	TTT	968	970	TTA	39;39;37	T;T;A	39;39;37	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2814	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3126	48.0	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1151	1153	AAT	46;46;46	A;A;T	46;46;46	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2814	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3126	48.0	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1938	1938	T	59	T	59	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	790	acrR_2	648	648	99.54	acrR_2.l6.c30.ctg.1	1237	34.3	1	SNP	p	R45C	0	.	.	133	135	CGC	476	478	CGC	62;62;62	C;G;C	61;61;62	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	664	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1132	31.3	0	.	p	.	0	L34F	NONSYN	100	102	CTC	340	342	TTC	20;20;20	T;T;C	20;20;20	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	664	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1132	31.3	0	.	p	.	0	E122G	NONSYN	364	366	GAG	604	606	GGG	60;59;58	G;G;G	60;59;58	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	1048	adiY	762	762	99.61	adiY.l6.c30.ctg.1	1238	45.2	0	.	p	.	0	V136L	NONSYN	406	408	GTT	661	663	CTT	74;72;71	C;T;T	74;72;71	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2694	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3285	44.1	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2181	2183	GCA	51;51;52	G;C;A	51;51;52	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2694	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3285	44.1	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2442	2444	ACC	51;52;54	A;C;C	51;52;54	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2694	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3285	44.1	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2751	2753	GCC	48;49;50	G;C,T;C	47;48,1;50	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1552	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2232	36.3	0	.	p	.	0	G37A	NONSYN	109	111	GGT	298	300	GCT	10;11;13	G;C;T	10;11;13	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1552	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2232	36.3	0	.	p	.	0	D77E	NONSYN	229	231	GAT	418	420	GAG	19;19;19	G;A;G	19;19;19	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1552	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2232	36.3	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	454	456	TGC	22;21;20	T;G;C	22;21;20	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1552	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2232	36.3	0	.	p	.	0	I150V	NONSYN	448	450	ATT	637	639	GTT	24;25;28	G;T;T	24;25;28	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1552	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2232	36.3	0	.	p	.	0	R200H	NONSYN	598	600	CGC	787	789	CAC	35;34;35	C;A;C	34;34;35	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1552	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2232	36.3	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1072	1074	ATG	56;57;57	A;T;G	56;56;56	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1552	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2232	36.3	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2068	2070	CGC	34;34;34	C;G,C;C	34;33,1;34	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	738	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1357	29.2	0	.	p	.	0	S221T	NONSYN	661	663	AGC	956	958	ACC	24;24;23	A;C;C	24;24;23	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	738	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1357	29.2	0	.	p	.	0	P225S	NONSYN	673	675	CCG	968	970	TCG	28;27;30	T;C;G	28;27;30	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	600	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1205	26.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1198	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1932	33.2	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1381	1383	AAA	28;29;29	A;A;A	28;29;29	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1198	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1932	33.2	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1393	1395	GAG	25;25;27	G;A;G	25;24;27	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1198	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1932	33.2	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1399	1401	CAC	30;33;33	C,G;A;C	29,1;33;33	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1198	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1932	33.2	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1453	1455	GAG	34;33;34	G;A;G	34;33;34	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1340	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	2002	35.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	900	cpxR	699	699	99.43	cpxR.l6.c4.ctg.1	1261	38.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	924	cysB	975	975	99.28	cysB.l6.c30.ctg.1	1561	31.9	0	.	p	.	0	A146T	NONSYN	436	438	GCT	732	734	ACT	49;47;47	A;C;T	49;47;46	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	584	dfrA1_1	474	474	100.0	dfrA1_1.l15.c30.ctg.1	934	33.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli;dfrA1
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1222	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1841	35.7	0	.	p	.	0	I219V	NONSYN	655	657	ATC	1013	1015	GTC	48;49;48	G;T;C	46;49;48	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1558	emrB	1539	1539	99.74	emrB.l15.c30.ctg.1	2118	39.5	0	.	p	.	0	E197K	NONSYN	589	591	GAA	884	886	AAA	48;48;49	A;A;A	48;47;47	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1098	emrD	1191	1191	98.4	emrD.l15.c30.ctg.1	1680	35.0	0	.	p	.	0	G209S	NONSYN	625	627	GGC	879	881	AGC	38;38;38	A;G;C	38;37;37	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	80	emrE_1	333	95	96.84	emrE_1.l6.c4.ctg.2	294	9.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1000	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1624	32.9	0	.	p	.	0	K176R	NONSYN	526	528	AAG	802	804	AGG	39;38;37	A;G;G	38;38;37	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1000	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1624	32.9	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1192	1194	GAC	27;24;24	G;A;C	27;24;24	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	754	emrR	531	531	100.0	emrR.l6.c30.ctg.1	1091	36.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1570	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	2046	41.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	658	evgA	615	615	99.19	evgA.l6.c30.ctg.1	1192	29.6	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	437	439	CTG	52;51;51	C;T;G	52;51;50	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	T38I	NONSYN	112	114	ACA	388	390	ATA	27;26;24	A;T;A	27;26;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	L42V	NONSYN	124	126	CTA	400	402	GTA	21;21;21	G;T;A	21;21;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	A93T	NONSYN	277	279	GCG	553	555	ACG	33;32;30	A;C;G	33;32;30	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	A114E	NONSYN	340	342	GCA	616	618	GAA	23;24;23	G;A;A	23;23;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	T127A	NONSYN	379	381	ACT	655	657	GCT	27;26;25	G;C;T	27;26;25	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	N133D	NONSYN	397	399	AAT	673	675	GAT	28;27;28	G;A;T	28;27;28	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	P162S	NONSYN	484	486	CCA	760	762	TCA	25;25;24	T;C;A	25;25;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	889	891	CAG	25;26;26	C;A;G	25;26;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1027	1029	GTT	36;35;35	G,A;T;T	35,1;35;35	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1183	1185	GAT	19;19;19	G;A;T	19;18;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1351	1353	AAT	26;28;28	A;A;T	26;28;28	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1372	1374	TTA	19;19;19	T;T;A	19;18;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1573	1575	AAA	30;28;28	A;A;A	30;28;28	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2308	2310	CAT	40;38;38	C;A;T	40;38;38	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2362	2364	CAT	20;21;21	C;A;T	20;20;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2380	2382	AGA	26;26;27	A;G;A	26;26;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2395	2397	AAT	28;28;28	A;A;T	28;28;28	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2542	2544	TCC	23;23;21	T;C;C	23;23;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2707	2709	ATT	35;35;34	A;T;T	35;35;34	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2728	2730	GAT	32;34;33	G;A;T	32;33;33	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2842	2844	GTT	50;50;50	G;T;T	50;50;50	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2942	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	4079	38.7	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3127	3129	CAC	53;52;51	C,A;A;C	52,1;51;50	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	898	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1338	36.0	1	SNP	p	P64A	0	.	.	190	192	CCA	428	430	CCA	54;57;58	C;C;A	54;57;54	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	898	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1338	36.0	1	SNP	p	P64L	0	.	.	190	192	CCA	428	430	CCA	54;57;58	C;C;A	54;57;54	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	898	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1338	36.0	1	SNP	p	P64H	0	.	.	190	192	CCA	428	430	CCA	54;57;58	C;C;A	54;57;54	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	898	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1338	36.0	1	SNP	p	P64S	0	.	.	190	192	CCA	428	430	CCA	54;57;58	C;C;A	54;57;54	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	898	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1338	36.0	1	SNP	p	P64R	0	.	.	190	192	CCA	428	430	CCA	54;57;58	C;C;A	54;57;54	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	720	gadE	528	528	100.0	gadE.l15.c4.ctg.1	1152	33.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	192	gadW	729	231	96.1	gadW.l6.c4.ctg.1	313	19.9	0	.	p	.	0	S234A	NONSYN	700	702	TCG	202	204	GCG	19;18;18	G;C;G	19;17;18	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	192	gadW	729	370	93.51	gadW.l6.c4.ctg.2	372	10.1	0	.	p	.	0	L46P	NONSYN	136	138	CTG	30	32	CCG	1;1;1	C;C;G	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	192	gadW	729	370	93.51	gadW.l6.c4.ctg.2	372	10.1	0	.	p	.	0	E54D	NONSYN	160	162	GAA	54	56	GAT	6;6;6	G;A;T	6;6;6	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	192	gadW	729	370	93.51	gadW.l6.c4.ctg.2	372	10.1	0	.	p	.	0	I88M	NONSYN	262	264	ATA	156	158	ATG	6;5;5	A;T;G	6;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	192	gadW	729	370	93.51	gadW.l6.c4.ctg.2	372	10.1	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	159	161	CCG	4;4;4	C;C;G	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	192	gadW	729	370	93.51	gadW.l6.c4.ctg.2	372	10.1	0	.	p	.	0	D100E	NONSYN	298	300	GAC	192	194	GAA	5;6;6	G;A;A	5;6;6	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	192	gadW	729	370	93.51	gadW.l6.c4.ctg.2	372	10.1	0	.	p	.	0	P101S	NONSYN	301	303	CCC	195	197	TCC	6;6;6	T;C;C	6;6;6	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	192	gadW	729	370	93.51	gadW.l6.c4.ctg.2	372	10.1	0	.	p	.	0	R102G	NONSYN	304	306	CGG	198	200	GGG	6;6;6	G;G;G	6;6;6	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	192	gadW	729	370	93.51	gadW.l6.c4.ctg.2	372	10.1	0	.	p	.	0	K110N	NONSYN	328	330	AAA	222	224	AAT	6;6;5	A;A;T	6;6;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	708	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1386	27.5	0	.	p	.	0	F53L	NONSYN	157	159	TTC	449	451	TTA	45;40;40	T;T;A	45;40;40	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	708	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1386	27.5	0	.	p	.	0	V79I	NONSYN	235	237	GTT	527	529	ATT	35;34;35	A;T;T	35;34;35	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	708	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1386	27.5	0	.	p	.	0	R246G	NONSYN	736	738	AGA	1028	1030	GGA	24;23;25	G;G;A	24;23;25	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	708	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1386	27.5	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1034	1036	CCG	22;21;22	C;C;G	22;21;22	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2630	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3244	43.6	1	SNP	p	S83L	1	S83L	NONSYN	247	249	TCG	552	554	TTG	37;33;33	T;T;G	37;32;33	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2630	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3244	43.6	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2337	2339	GAA	57;56;55	G;A;A	57;56;54	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2630	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3244	43.6	1	SNP	p	D87N	0	.	.	259	261	GAC	564	566	GAC	33;35;38	G;A;C	33;34;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2630	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3244	43.6	1	SNP	p	D87H	0	.	.	259	261	GAC	564	566	GAC	33;35;38	G;A;C	33;34;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2630	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3244	43.6	1	SNP	p	D87V	0	.	.	259	261	GAC	564	566	GAC	33;35;38	G;A;C	33;34;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2630	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3244	43.6	1	SNP	p	D87G	0	.	.	259	261	GAC	564	566	GAC	33;35;38	G;A;C	33;34;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2630	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3244	43.6	1	SNP	p	D87Y	0	.	.	259	261	GAC	564	566	GAC	33;35;38	G;A;C	33;34;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2432	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3031	43.1	1	SNP	p	R136H	0	.	.	406	408	CGC	725	727	CGC	52;52;51	C;G;C	51;51;51	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2432	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3031	43.1	1	SNP	p	R136E	0	.	.	406	408	CGC	725	727	CGC	52;52;51	C;G;C	51;51;51	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2432	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3031	43.1	1	SNP	p	R136L	0	.	.	406	408	CGC	725	727	CGC	52;52;51	C;G;C	51;51;51	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2432	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3031	43.1	1	SNP	p	R136I	0	.	.	406	408	CGC	725	727	CGC	52;52;51	C;G;C	51;51;51	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2432	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3031	43.1	1	SNP	p	R136G	0	.	.	406	408	CGC	725	727	CGC	52;52;51	C;G;C	51;51;51	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2432	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3031	43.1	1	SNP	p	R136S	0	.	.	406	408	CGC	725	727	CGC	52;52;51	C;G;C	51;51;51	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2432	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3031	43.1	1	SNP	p	R136C	0	.	.	406	408	CGC	725	727	CGC	52;52;51	C;G;C	51;51;51	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	610	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1179	27.6	0	.	p	.	0	A72P	NONSYN	214	216	GCG	526	528	CCG	32;30;33	C;C,G;G	32;29,1;33	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	610	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1179	27.6	0	.	p	.	0	T123A	NONSYN	367	369	ACC	679	681	GCC	30;29;30	G;C;C	30;28;30	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1036	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1431	38.8	0	.	p	.	0	P9S	NONSYN	25	27	CCA	256	258	TCA	12;14;17	T;C;A	12;14;17	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	444	marA	384	384	99.74	marA.l15.c4.ctg.1	993	23.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	778	18.2	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	558	560	AGC	14;13;12	A;G;C	14;13;12	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	778	18.2	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	660	662	CAT	7;5;5	C;A;T	6;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	778	18.2	1	SNP	p	V45E	0	.	.	133	135	GTG	384	386	GTG	38;38;38	G;T;G	37;38;37	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	778	18.2	1	SNP	p	I49S	0	.	.	145	147	ATC	396	398	ATC	43;41;41	A;T;C	43;41;41	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	778	18.2	1	SNP	p	A70T	0	.	.	208	210	GCA	459	461	GCA	31;31;32	G;C;A	31;31;32	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	778	18.2	1	SNP	p	R73C	0	.	.	217	219	CGT	468	470	CGT	30;30;29	C;G;T	30;30;28	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	778	18.2	1	SNP	p	R73S	0	.	.	217	219	CGT	468	470	CGT	30;30;29	C;G;T	30;30;28	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	778	18.2	1	SNP	p	R77L	0	.	.	229	231	CGC	480	482	CGC	28;29;28	C;G;C	28;29;28	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	778	18.2	1	SNP	p	R77C	0	.	.	229	231	CGC	480	482	CGC	28;29;28	C;G;C	28;29;28	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	778	18.2	1	SNP	p	L78M	0	.	.	232	234	CTG	483	485	CTG	28;29;29	C;T;G	28;29;29	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	778	18.2	1	SNP	p	R94H	0	.	.	280	282	CGC	531	533	CGC	21;22;22	C;G;C	21;22;22	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	778	18.2	1	SNP	p	R94S	0	.	.	280	282	CGC	531	533	CGC	21;22;22	C;G;C	21;22;22	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	270	marR	435	435	97.7	marR.l15.c4.ctg.1	778	18.2	1	SNP	p	V96E	0	.	.	286	288	GTA	537	539	GTA	19;19;19	G;T;A	19;19;19	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	930	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1595	31.1	0	.	p	.	0	S7F	NONSYN	19	21	TCC	201	203	TTC	7;7;7	T;T;C	7;7;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	930	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1595	31.1	0	.	p	.	0	R36I	NONSYN	106	108	AGG	288	290	ATC	13;12;10	A;T;C	13;11;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	930	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1595	31.1	0	.	p	.	0	E42A	NONSYN	124	126	GAA	306	308	GCC	2;2;3	G;C;C	2;2;3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	930	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1595	31.1	0	.	p	.	0	N43V	NONSYN	127	129	AAT	309	311	GTG	3;3;3	G;T;G	3;3;3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	930	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1595	31.1	0	.	p	.	0	E52D	NONSYN	154	156	GAG	336	338	GAT	9;11;11	G;A;T	9;11;11	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	930	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1595	31.1	0	.	p	.	0	N59T	NONSYN	175	177	AAC	357	359	ACC	21;21;20	A;C;C	20;21;19	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	930	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1595	31.1	0	.	p	.	0	I68L	NONSYN	202	204	ATA	384	386	TTA	22;23;23	T;T;A	22;23;23	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	930	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1595	31.1	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	525	527	CAG	55;55;55	C;A;G	55;55;55	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	930	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1595	31.1	0	.	p	.	0	D128A	NONSYN	382	384	GAC	564	566	GCC	41;42;44	G;C;C	41;42;44	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	930	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1595	31.1	0	.	p	.	0	S163A	NONSYN	487	489	TCG	669	671	GCG	46;46;48	G;C;G	46;46;48	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	930	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1595	31.1	0	.	p	.	0	L231V	NONSYN	691	693	CTT	873	875	GTT	37;37;40	G;T;T,G	36;36;38,1	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	930	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1595	31.1	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1035	1035	C	41	C	41	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	866	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1801	25.7	0	.	p	.	0	V12trunc	TRUNC	34	34	G	355	355	G	40	G	40	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	866	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1801	25.7	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	412	414	CAG	27;29;30	C;A;G	27;28;30	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	866	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1801	25.7	0	.	p	.	0	T83I	NONSYN	247	249	ACC	562	564	ATC	28;26;25	A;T;C	27;25;25	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	866	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1801	25.7	0	.	p	.	0	I99M	NONSYN	295	297	ATA	610	612	ATG	24;23;23	A;T;G	24;23;23	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	866	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1801	25.7	0	.	p	.	0	A130T	NONSYN	388	390	GCC	703	705	ACC	22;22;22	A;C;C	22;22;22	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	866	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1801	25.7	0	.	p	.	0	P257T	NONSYN	769	771	CCG	1084	1086	ACG	38;38;40	A;C;G	38;38;40	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2860	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3499	44.0	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1998	2000	ACC	52;51;50	A;C;C	52;51;50	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2860	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3499	44.0	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2391	2393	CAA	38;37;38	C;A;A	38;37;38	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2860	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3499	44.0	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2559	2561	ATT	31;29;29	A;T;T	31;29;29	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2860	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3499	44.0	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2643	2645	GTT	46;46;47	G,C;T;T	45,1;44;46	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2860	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3499	44.0	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2751	2753	GAG	37;39;41	G;A;G	36;37;41	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2860	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3499	44.0	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2979	2981	ATG	29;30;31	A;T;G	29;30;31	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2860	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3499	44.0	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3114	3116	GAT	36;36;36	G;A;T	36;33;36	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2568	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3660	37.7	0	.	p	.	0	I46M	NONSYN	136	138	ATC	456	458	ATG	24;23;23	A;T;G	24;22;23	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2568	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3660	37.7	0	.	p	.	0	V208I	NONSYN	622	624	GTC	942	944	ATC	57;58;58	A;T;C	56;57;58	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2568	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3660	37.7	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3258	3260	CAC	7;7;7	C;A;C	7;7;7	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2568	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3660	37.7	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3261	3263	CTC	7;7;7	C;T;C	7;7;7	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1342	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1870	38.3	0	.	p	.	0	D3E	NONSYN	7	9	GAT	219	221	GAA	25;24;23	G;A;A	25;24;22	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1342	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1870	38.3	0	.	p	.	0	T226A	NONSYN	676	678	ACG	888	890	GCG	48;46;48	G;C;G	48;45;47	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1342	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1870	38.3	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1230	1232	ATC	42;41;40	A;T,G;C	41;40,1;40	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1342	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1870	38.3	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1533	1535	TTT	54;57;57	T;T;T	54;57;57	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1334	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1691	42.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3240	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3671	47.4	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1185	1187	ACC	44;43;43	A;C;C	43;41;43	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3240	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3671	47.4	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2427	2429	GAC	58;57;59	G;A;C	58;56;58	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1338	mdtG	1227	1047	99.33	mdtG.l15.c30.ctg.1	1636	35.3	0	.	p	.	0	V200I	NONSYN	598	600	GTC	717	719	ATC	38;39;41	A;T;C	38;37;41	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1338	mdtG	1227	182	99.45	mdtG.l15.c30.ctg.2	676	20.2	0	.	p	.	0	E5G	NONSYN	13	15	GAA	173	175	GGA	22;22;23	G;G,A;A	21;20,1;23	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1004	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1584	33.8	0	.	p	.	0	G134C	NONSYN	400	402	GGT	630	632	TGT	27;28;27	T,A;G;T	26,1;28;27	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1004	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1584	33.8	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1200	1202	TTG	41;41;39	T;T;G	41;41;39	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1004	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1584	33.8	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1410	1412	ACG	17;16;15	A;C;G	16;16;15	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1130	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1756	34.4	0	.	p	.	0	A185S	NONSYN	553	555	GCC	855	857	TCC	33;33;32	T;C;C	31;33;32	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	902	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1619	29.9	0	.	p	.	0	V119I	NONSYN	355	357	GTT	660	662	ATT	23;24;24	A;T;T	23;24;24	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1886	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2465	41.0	0	.	p	.	0	V11M	NONSYN	31	33	GTG	223	225	ATG	25;28;29	A;T;G	25;28;29	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1886	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2465	41.0	0	.	p	.	0	T33I	NONSYN	97	99	ACC	289	291	ATC	28;30;30	A;T;C	26;28;29	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1886	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2465	41.0	0	.	p	.	0	C116R	NONSYN	346	348	TGC	538	540	CGC	49;47;46	C;G;C	49;47;46	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1886	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2465	41.0	0	.	p	.	0	N238S	NONSYN	712	714	AAC	904	906	AGC	41;40;37	A;G;C	41;39;37	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1886	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2465	41.0	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1105	1107	GTG	35;37;37	G;T;G	35;36;37	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1886	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2465	41.0	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1168	1170	AAC	26;23;26	A;A;C	25;21;24	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1886	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2465	41.0	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1213	1215	GTC	38;38;39	G;T;C	38;37;39	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1886	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2465	41.0	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1243	1245	ATA	36;35;36	A;T;A	36;35;36	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1886	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2465	41.0	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1351	1353	TCT	44;43;44	T;C;T	44;43;44	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1886	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2465	41.0	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1738	1740	GCG	56;56;55	G,T;C;G	54,1;55;55	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1886	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2465	41.0	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1951	1953	ATC	58;56;57	A;T;C	58;56;56	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1246	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1861	35.7	0	.	p	.	0	S129A	NONSYN	385	387	TCA	593	595	GCG	44;46;47	G;C;G	44;46;47	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1246	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1861	35.7	0	.	p	.	0	A187T	NONSYN	559	561	GCC	767	769	ACC	63;64;64	A;C;C	63;64;64	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1246	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1861	35.7	0	.	p	.	0	H211R	NONSYN	631	633	CAC	839	841	CGC	54;55;59	C;G;C	54;54;59	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1246	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1861	35.7	0	.	p	.	0	V250A	NONSYN	748	750	GTT	956	958	GCT	31;33;31	G;C;T	30;32;31	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1246	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1861	35.7	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1040	1042	AAA	33;32;33	A;A;A	33;32;33	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1246	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1861	35.7	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1058	1060	CGA	34;34;33	C;G;A	34;34;33	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1246	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1861	35.7	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1223	1225	GCC	38;37;36	G;C;C	38;37;36	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1246	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1861	35.7	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1235	1237	GAT	35;35;38	G;A;T	35;35;38	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1246	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1861	35.7	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1652	1654	GCT	22;21;18	G;C;T	22;21;18	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3094	mfd	3447	3447	99.13	mfd.l6.c4.ctg.1	3933	42.2	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1542	1544	AAG	21;22;21	A;A;G	21;22;21	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3094	mfd	3447	3447	99.13	mfd.l6.c4.ctg.1	3933	42.2	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2619	2621	CTG	46;46;45	C;T;G	46;45;45	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	194	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	663	15.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1808	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2220	43.7	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1031	1033	AAC	39;41;42	A;A;C	39;41;41	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1808	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2220	43.7	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1577	1579	ATA	55;55;55	A;T,C;A	55;54,1;55	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1300	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1760	39.4	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1393	1395	GAT	61;57;57	G;A;T	61;56;56	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1300	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1760	39.4	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1396	1398	CTG	53;53;55	C;T;G	53;53;54	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	644	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1201	28.5	0	.	p	.	0	R27C	NONSYN	79	81	CGT	287	289	TGT	41;41;41	T;G;T	41;41;41	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	644	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1201	28.5	0	.	p	.	0	I117T	NONSYN	349	351	ATC	557	559	ACC	33;32;32	A;C;C	30;31;32	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	644	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1201	28.5	0	.	p	.	0	G187D	NONSYN	559	561	GGC	767	769	GAC	33;33;34	G;A;C,A	33;33;33,1	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	644	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1201	28.5	1	SNP	p	R15C	0	.	.	43	45	CGC	251	253	CGC	48;48;47	C;G;C	48;48;47	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	644	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1201	28.5	1	SNP	p	S33R	0	.	.	97	99	AGC	305	307	AGC	43;43;42	A;G;C	43;43;42	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	644	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1201	28.5	1	SNP	p	G131D	0	.	.	391	393	GGC	599	601	GGC	27;27;28	G;G;C	27;27;28	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	644	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1201	28.5	1	SNP	p	R203C	0	.	.	607	609	CGT	815	817	CGT	37;35;34	C;G;T	37;35;34	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	644	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1201	28.5	1	SNP	p	R203L	0	.	.	607	609	CGT	815	817	CGT	37;35;34	C;G;T	37;35;34	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1224	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1581	41.3	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1147	1149	GAG	42;42;42	G;A;G	42;41;42	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1224	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1581	41.3	1	SNP	p	G141D	0	.	.	421	423	GGT	634	636	GGT	68;67;68	G;G;T,G	68;67;67,1	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1224	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1581	41.3	1	SNP	p	G141E	0	.	.	421	423	GGT	634	636	GGT	68;67;68	G;G;T,G	68;67;67,1	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1224	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1581	41.3	1	SNP	p	R154D	0	.	.	460	462	CGT	673	675	CGT	58;61;60	C;G;T	58;61;59	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1224	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1581	41.3	1	SNP	p	R154A	0	.	.	460	462	CGT	673	675	CGT	58;61;60	C;G;T	58;61;59	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2522	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2833	47.9	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1846	1848	GTG	42;43;41	G;T;G,T	41;41;40,1	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2522	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2833	47.9	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1873	1875	TCG	54;55;56	T;C;G	52;53;56	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2522	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2833	47.9	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2488	2490	AAC	33;32;30	A;A;C	32;31;29	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2522	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2833	47.9	1	SNP	p	A85T	0	.	.	253	255	GCG	502	504	GCG	60;61;60	G;C;G	60;59;60	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2522	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2833	47.9	1	SNP	p	D111H	0	.	.	331	333	GAT	580	582	GAT	47;50;50	G;A;T	46;49;49	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2522	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2833	47.9	1	SNP	p	S129P	0	.	.	385	387	TCC	634	636	TCC	65;63;64	T;C;C	63;63;63	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1606	parE_1	1893	1893	97.52	parE_1.l6.c4.ctg.1	2456	35.1	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1719	1721	AAC	44;46;49	A;A;C	44;46;49	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1606	parE_1	1893	1893	97.52	parE_1.l6.c4.ctg.1	2456	35.1	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1728	1730	GAT	56;58;58	G;A;T	56;58;58	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1496	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1995	40.2	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	910	912	CAG	50;49;48	C;A;G	50;49;47	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1496	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1995	40.2	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1384	1386	GAT	52;51;51	G;A;T	52;50;51	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4534	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4601	53.0	1	SNP	p	V146F	0	.	.	436	438	GTT	691	693	GTT	53;53;53	G;T;T	53;53;53	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4534	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4601	53.0	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1792	1794	CAG	84;83;82	C;A;G	83;83;81	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4534	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4601	53.0	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1792	1794	CAG	84;83;82	C;A;G	83;83;81	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4534	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4601	53.0	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1831	1833	CAC	60;58;58	C;A;C	60;58;58	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4534	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4601	53.0	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1840	1842	CGT	52;51;48	C;G;T	52;50;48	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4534	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4601	53.0	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1840	1842	CGT	52;51;48	C;G;T	52;50;48	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4534	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4601	53.0	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1846	1848	TCC	49;50;50	T;C;C	48;50;50	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4534	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4601	53.0	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1852	1854	CTC	47;46;45	C;T;C	47;46;45	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4534	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4601	53.0	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1942	1944	ACC	48;48;47	A;C;C	48;48;47	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4534	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4601	53.0	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1945	1947	CCT	50;54;55	C;C;T	50;54;55	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4534	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4601	53.0	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2314	2316	CGT	57;57;57	C;G;T	56;57;55	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1149	359.4	0	.	n	.	0	A226G	SNP	226	226	A	375	375	G	391	G	391	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1149	359.4	1	SNP	n	A794T	0	.	.	794	794	A	943	943	A	397	A	392	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1149	359.4	1	SNP	n	A794G	0	.	.	794	794	A	943	943	A	397	A	392	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1149	359.4	1	SNP	n	G926A	0	.	.	926	926	G	1075	1075	G	393	G,T	391,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1149	359.4	1	SNP	n	G926C	0	.	.	926	926	G	1075	1075	G	393	G,T	391,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1149	359.4	1	SNP	n	G926T	0	.	.	926	926	G	1075	1075	G	393	G,T	391,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1149	359.4	0	HET	.	.	.	A79G	.	79	79	A	228	228	A	348	A,G	259,88	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1149	359.4	0	HET	.	.	.	C719T	.	719	719	C	868	868	C	363	C,T	207,155	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1149	359.4	0	HET	.	.	.	T273A	.	273	273	T	422	422	T	348	T,A	260,85	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1149	359.4	0	HET	.	.	.	C183T	.	183	183	C	332	332	C	385	C,T	258,124	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1149	359.4	0	HET	.	.	.	A250T,C	.	250	250	A	399	399	A	354	A,T,C	281,66,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1149	359.4	0	HET	.	.	.	T90C	.	90	90	T	239	239	T	349	T,C	260,89	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1149	359.4	0	HET	.	.	.	G474A	.	474	474	G	623	623	G	398	G,A	291,106	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1149	359.4	0	HET	.	.	.	A253T	.	253	253	A	402	402	A	341	A,T	273,64	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1149	359.4	0	HET	.	.	.	C194T	.	194	194	C	343	343	C	399	C,T	317,81	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	502	100.0	rrsB+.l15.c30.ctg.2	516	401.7	1	SNP	n	A1519T	0	.	.	1519	1519	A	479	479	A	269	A	264	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	502	100.0	rrsB+.l15.c30.ctg.2	516	401.7	1	SNP	n	A1519C	0	.	.	1519	1519	A	479	479	A	269	A	264	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	502	100.0	rrsB+.l15.c30.ctg.2	516	401.7	1	SNP	n	A1519G	0	.	.	1519	1519	A	479	479	A	269	A	264	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	143	95.14	rrsB+.l15.c30.ctg.3	143	81.9	0	.	n	.	0	G1002A	SNP	1002	1002	G	54	54	A	107	A	107	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	143	95.14	rrsB+.l15.c30.ctg.3	143	81.9	0	.	n	.	0	G1006C	SNP	1006	1006	G	58	58	C	114	C	114	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	143	95.14	rrsB+.l15.c30.ctg.3	143	81.9	0	.	n	.	0	T1010C	SNP	1010	1010	T	62	62	C	118	C	118	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	143	95.14	rrsB+.l15.c30.ctg.3	143	81.9	0	.	n	.	0	A1019.	DEL	1019	1019	A	70	70	G	120	G,A	119,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	143	95.14	rrsB+.l15.c30.ctg.3	143	81.9	0	.	n	.	0	.1023G	INS	1023	1023	T	75	75	G	120	G	119	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	143	95.14	rrsB+.l15.c30.ctg.3	143	81.9	0	.	n	.	0	C1038T	SNP	1038	1038	C	90	90	T	134	T	134	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	12962	rrsB+	1542	143	100.0	rrsB+.l15.c30.ctg.6	143	102.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	694	sat_1	525	525	100.0	sat_1.l15.c4.ctg.1	1112	33.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	572	soxR	465	465	100.0	soxR.l15.c4.ctg.1	945	32.3	1	SNP	p	R20H	0	.	.	58	60	CGC	275	277	CGC	43;43;43	C;G;C	43;43;43	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	572	soxR	465	465	100.0	soxR.l15.c4.ctg.1	945	32.3	1	SNP	p	G121D	0	.	.	361	363	GGT	578	580	GGT	39;37;39	G;G;T	39;37;39	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	462	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	916	27.1	1	SNP	p	A12S	0	.	.	34	36	GCA	323	325	GCA	55;57;56	G;C;A	55;57;56	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	1528	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l15.c4.ctg.1	1411	58.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	1580	APH_6__Id+	837	837	100.0	APH_6__Id+.l15.c4.ctg.1	1342	63.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.3000412.AY055428.20268_21084.552	sul2.3000412.AY055428.20268_21084.552	1	0	27	1174	sul2	816	816	100.0	sul2.l15.c30.ctg.1	1431	44.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Sul2 is a sulfonamide resistant dihydropteroate synthase of Gram-negative bacteria, usually found on small plasmids.;sul2
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	1878	tetA	1200	1200	100.0	tetA.l6.c30.ctg.1	1840	54.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	1108	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1179	50.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1686	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	2099	43.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
